FDA Warns of Possible Adverse Reaction to Diabetes Drug Ozempic, Updates Labels

It follows reports of a condition that interrupts the normal function of the intestines in some individuals who have used the medication.

Mario Tama/Getty Images

Labels on the diabetes drug Ozempic have been updated to acknowledge reports of a condition that interrupts the normal function of the intestines in some individuals who have used the medication.

The U.S. Food and Drug Administration (FDA) made the label update for the drug on Sept. 22.